Sastasundar Ventures Limited — Investor Meet, 25-11-2024: Analysts/Institutional Investor Meet/Con. Call Updates

1. **Financial Performance:** SastaSundar Ventures reported revenues of ₹1,352 crore for FY24, with the B2C platform generating ₹863 crore and RetailerShakti contributing ₹489 crore. For FY25, revenues are expected to decline to around ₹1,191 crore, with a projected revenue of ₹1,000 crore from RetailerShakti and ₹200 crore from SastaSundar. The company achieved an EBITDA margin of 2% for SastaSundar and 0.9% for RetailerShakti, indicating stable profitability despite the overall revenue dip.

2. **Future Outlook and Growth Drivers:** The management expressed optimism, anticipating a return to growth post uncertainties related to the Flipkart deal. They aim for substantial revenue growth, projecting total revenue of ₹6,600 crore by 2030, with 60% from SastaSundar and 36% from RetailerShakti. The strategy includes enhancing efficiency and fulfilling sustainable market demands while leveraging their fully capitalized status.

3. **Order Book and Operational Updates:** The company is focused on expanding its Healthbuddy network and plans to grow its RetailerShakti business with consistent warehouse expansion. Currently, the platform boasts around 37,000 SKUs, with plans to further expand this portfolio.

4. **Analyst Q&A Insights:**

- *Revenue and Profitability:* Analysts sought clarity on revenue projections; management maintained confidence in achieving profitability in RetailerShakti by FY26 with growing volumes and improved efficiency.

- *Market Position and Competitive Landscape:* The company differentiates through its local operational strengths and service differentiation, positioning itself favorably against established competitors.

- *Operational Challenges or Risks:* Concerns about upcoming regulatory changes and competition were addressed with reassurances of compliance and preparedness for adaptation.

- *Capex and Capital Allocation:* With ₹675 crore in cash, SastaSundar plans to judiciously invest ₹145 crore toward strategic enhancements, primarily through operational expenses rather than capitalizing these investments.

- *Strategic Priorities and Long-Term Vision:* The vision emphasizes the integration of AI and data utilization to enhance service delivery, setting the stage for evolving customer engagement in healthcare.

5. **Market or Regulatory Updates:** The regulatory landscape has shifted favorably for e-pharmacy, with prior uncertainties significantly reduced. Ongoing compliance and adaptation will be critical as new guidelines emerge.

6. **Strategic Focus Areas:** SastaSundar is committed to developing a unique Healthbuddy model, focusing on both B2B and B2C channels, while harnessing technology and operational efficiencies to capture market share.

7. **Investor Insight:** The financial health and growth potential indicate a cautious 'buy' position, particularly given the expected revenue recovery and manageable operational risks. The increasing clarity on regulatory frameworks and the shift towards sustainable business practices bolster investor confidence in the company's long-term trajectory.